Guselkemab vs. Ustekinumab in PsA: Dr. Richard Conway Save Nov 09, 2021 1:59 pm Dr. Conway discusses abstract #1773 presented at the ACR21 annual meeting. ADD THE FIRST COMMENT If you are a health practitioner, you may Login/Register to comment.Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.